KEGG   PATHWAY: biu05416
Entry
biu05416                    Pathway                                
Name
Viral myocarditis - Bos indicus (zebu cattle)
Description
Myocarditis is a cardiac disease associated with inflammation and injury of the myocardium. It results from various etiologies, both noninfectious and infectious, but coxsackievirus B3 (CVB3) is still considered the dominant etiological agent. Myocarditis may be caused by direct cytopathic effects of virus, a pathologic immune response to persistent virus, or autoimmunity triggered by the viral infection. The virus enters the myocyte through internalization of the coxsackie-adenoviral receptor (CAR) and its coreceptor, decay-accelerating factor (DAF). Viral proteases cleave various proteins in the host cell. One example is viral protease 2A, which cleaves eukaryote initiation factor 4G (eIF4G) and the dystrophin protein, resulting in a complete shutdown of cap-dependent RNA translation and cytoskeletal destruction in infected cardiomyocytes, respectively. CVB3 also cleaves the member of the Bcl-2 family Bid, leading to apoptosis. CVB3 infection also induces the cleavage of cyclin D protein through a proteasome-dependent pathway, leading to the host cell-growth arrest. Viral infection and necrosis of myocytes may lead to the release of intracellular antigens, resulting in activation of self-reactive T cells. CVB infection is a significant cause of dilated cardiomyopathy (DCM) as well as myocarditis. Epidemiologically, myocarditis underlies a significant portion of patients with DCM.
Class
Human Diseases; Cardiovascular disease
Pathway map
biu05416  Viral myocarditis
biu05416

Organism
Bos indicus (zebu cattle) [GN:biu]
Gene
109559838  CXADR; coxsackievirus and adenovirus receptor isoform X1 [KO:K06788]
109563811  FYN; tyrosine-protein kinase Fyn isoform X1 [KO:K05703] [EC:2.7.10.2]
109557414  CAV1; caveolin-1 isoform X1 [KO:K06278]
109566554  ABL1; tyrosine-protein kinase ABL1 [KO:K06619] [EC:2.7.10.2]
109570619  ABL2; Abelson tyrosine-protein kinase 2 isoform X1 [KO:K08887] [EC:2.7.10.2]
109578192  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
109559531  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
109574290  RAC3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
109559576  SSPN; sarcospan [KO:K22194]
109574034  SGCA; alpha-sarcoglycan [KO:K12565]
109560461  SGCB; beta-sarcoglycan [KO:K12566]
109566849  SGCG; gamma-sarcoglycan [KO:K12564]
109562240  SGCD; delta-sarcoglycan [KO:K12563]
109558217  SGCE; epsilon-sarcoglycan isoform X1 [KO:K27061]
109577666  LAMA1; laminin subunit alpha-1 [KO:K05637]
109563534  LAMA2; LOW QUALITY PROTEIN: laminin subunit alpha-2 [KO:K05637]
109576023  DAG1; dystroglycan isoform X1 [KO:K06265]
109576337  CAV3; caveolin-3 [KO:K12959]
109571319  NOS1; nitric oxide synthase, brain [KO:K13240] [EC:1.14.13.39]
109567370  SNTA1; alpha-1-syntrophin [KO:K24063]
109571982  SNTB2; beta-2-syntrophin [KO:K24064]
109568538  SNTB1; beta-1-syntrophin isoform X1 [KO:K24064]
109577774  DTNA; dystrobrevin alpha isoform X1 [KO:K26998]
109573916  ACTG1; actin, cytoplasmic 2 [KO:K05692]
109578544  ACTB; actin, cytoplasmic 1 [KO:K05692]
109557358  EIF4G1; eukaryotic translation initiation factor 4 gamma 1 [KO:K03260]
109574225  EIF4G3; eukaryotic translation initiation factor 4 gamma 3 isoform X1 [KO:K03260]
109568820  EIF4G2; eukaryotic translation initiation factor 4 gamma 2 [KO:K03260]
109554439  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
109569521  CASP8; caspase-8 [KO:K04398] [EC:3.4.22.61]
109559782  BH3-interacting domain death agonist-like isoform X1 [KO:K04726]
109559783  BH3-interacting domain death agonist-like isoform X1 [KO:K04726]
109566483  cytochrome c [KO:K08738]
109566484  cytochrome c [KO:K08738]
109557512  cytochrome c [KO:K08738]
109570433  CASP9; caspase-9 [KO:K04399] [EC:3.4.22.62]
109553316  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
109564796  myosin-7 [KO:K17751]
109555532  CD40LG; CD40 ligand [KO:K03161]
109567510  CD40; tumor necrosis factor receptor superfamily member 5 isoform X1 [KO:K03160]
109576545  DLA class II histocompatibility antigen, DR-1 beta chain-like [KO:K06752]
109576596  HLA class II histocompatibility antigen, DO alpha chain-like isoform X1 [KO:K06752]
109577038  SLA class II histocompatibility antigen, DQ haplotype D alpha chain-like [KO:K06752]
109577039  SLA class II histocompatibility antigen, DQ haplotype D alpha chain [KO:K06752]
109577041  LOW QUALITY PROTEIN: DLA class II histocompatibility antigen, DR-1 beta chain-like [KO:K06752]
109577042  HLA class II histocompatibility antigen, DR alpha chain [KO:K06752]
109576666  DLA class II histocompatibility antigen, DR-1 beta chain-like [KO:K06752]
109577307  LOW QUALITY PROTEIN: HLA class II histocompatibility antigen, DM alpha chain [KO:K06752]
109577316  HLA class II histocompatibility antigen, DM beta chain isoform X1 [KO:K06752]
109576780  SLA class II histocompatibility antigen, DQ haplotype D alpha chain-like [KO:K06752]
109577067  BOLA class I histocompatibility antigen, alpha chain BL3-7-like isoform X1 [KO:K06751]
109577074  BOLA class I histocompatibility antigen, alpha chain BL3-6-like isoform X1 [KO:K06751]
109577076  BOLA class I histocompatibility antigen, alpha chain BL3-7-like isoform X1 [KO:K06751]
109577078  LOW QUALITY PROTEIN: BOLA class I histocompatibility antigen, alpha chain BL3-7-like [KO:K06751]
109577080  LOW QUALITY PROTEIN: BOLA class I histocompatibility antigen, alpha chain BL3-6-like [KO:K06751]
109577083  BOLA class I histocompatibility antigen, alpha chain BL3-7-like isoform X1 [KO:K06751]
109577088  BOLA class I histocompatibility antigen, alpha chain BL3-7 isoform X1 [KO:K06751]
109577113  LOW QUALITY PROTEIN: BOLA class I histocompatibility antigen, alpha chain BL3-7-like [KO:K06751]
109576723  LOW QUALITY PROTEIN: BOLA class I histocompatibility antigen, alpha chain BL3-6-like [KO:K06751]
109561936  H-2 class I histocompatibility antigen, Q10 alpha chain-like isoform X1 [KO:K06751]
109576990  CD80; T-lymphocyte activation antigen CD80 [KO:K05412]
109554436  CD86; T-lymphocyte activation antigen CD86 isoform X1 [KO:K05413]
109569809  CD28; T-cell-specific surface glycoprotein CD28 [KO:K06470]
109553933  PRF1; perforin-1 [KO:K07818]
109578145  ITGAL; integrin alpha-L [KO:K05718]
109560786  ITGB2; integrin beta-2 [KO:K06464]
109561581  intercellular adhesion molecule 1 [KO:K06490]
Reference
  Authors
Esfandiarei M, McManus BM
  Title
Molecular biology and pathogenesis of viral myocarditis.
  Journal
Annu Rev Pathol 3:127-55 (2008)
DOI:10.1146/annurev.pathmechdis.3.121806.151534
Reference
  Authors
Badorff C, Knowlton KU
  Title
Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.
  Journal
Med Microbiol Immunol 193:121-6 (2004)
DOI:10.1007/s00430-003-0189-7
Reference
  Authors
Maekawa Y, Ouzounian M, Opavsky MA, Liu PP
  Title
Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity.
  Journal
Circulation 115:5-8 (2007)
DOI:10.1161/CIRCULATIONAHA.106.670554
Reference
  Authors
Pankuweit S, Portig I, Maisch B
  Title
Pathophysiology of cardiac inflammation: molecular mechanisms.
  Journal
Herz 27:669-76 (2002)
DOI:10.1007/s00059-002-2421-4
Reference
  Authors
Gao G, Luo H
  Title
The ubiquitin-proteasome pathway in viral infections.
  Journal
Can J Physiol Pharmacol 84:5-14 (2006)
DOI:10.1139/y05-144
Reference
  Authors
Coyne CB, Bergelson JM
  Title
Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions.
  Journal
Cell 124:119-31 (2006)
DOI:10.1016/j.cell.2005.10.035
Reference
  Authors
Badorff C, Lee GH, Knowlton KU
  Title
Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex.
  Journal
Herz 25:227-32 (2000)
DOI:10.1007/s000590050011
Reference
  Authors
Knowlton KU
  Title
CVB infection and mechanisms of viral cardiomyopathy.
  Journal
Curr Top Microbiol Immunol 323:315-35 (2008)
DOI:10.1007/978-3-540-75546-3_15
Reference
  Authors
Castellano G, Affuso F, Di Conza P, Fazio S
  Title
Myocarditis and dilated cardiomyopathy: possible connections and treatments.
  Journal
J Cardiovasc Med (Hagerstown) 9:666-71 (2008)
DOI:10.2459/JCM.0b013e3282f3e9c2
Reference
  Authors
Cooper LT Jr
  Title
Myocarditis.
  Journal
N Engl J Med 360:1526-38 (2009)
DOI:10.1056/NEJMra0800028
Reference
  Authors
Kawai C
  Title
From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.
  Journal
Circulation 99:1091-100 (1999)
DOI:10.1161/01.CIR.99.8.1091
Reference
  Authors
Liu PP, Mason JW
  Title
Advances in the understanding of myocarditis.
  Journal
Circulation 104:1076-82 (2001)
DOI:10.1161/hc3401.095198
Reference
  Authors
Mason JW
  Title
Myocarditis and dilated cardiomyopathy: an inflammatory link.
  Journal
Cardiovasc Res 60:5-10 (2003)
DOI:10.1016/S0008-6363(03)00437-1
Reference
  Authors
Tam PE
  Title
Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease.
  Journal
Viral Immunol 19:133-46 (2006)
DOI:10.1089/vim.2006.19.133
Related
pathway
biu03050  Proteasome
biu04110  Cell cycle
biu04210  Apoptosis
biu04260  Cardiac muscle contraction
biu04512  ECM-receptor interaction
biu04612  Antigen processing and presentation
biu04660  T cell receptor signaling pathway
biu05414  Dilated cardiomyopathy
KO pathway
ko05416   
LinkDB

DBGET integrated database retrieval system